Andrew Lawrence - HistologiX Founder 1959-2023

In Loving Memory of Andrew Lawrence

It is with heavy hearts we announce the passing of one of our beloved founders, Andrew Lawrence, who left us in the summer after a short battle with pancreatic cancer. Our thoughts are with his family during this difficult time, and we extend our deepest condolences to all who knew and loved him.

Andrew was not only the visionary behind HistologiX but also a driving force in the field of drug development and research throughout his distinguished career. His unwavering commitment and hard work played a pivotal role in the establishment and growth of our company. Beyond his professional contributions, Andrew was a friend to all, known for his kindness, warmth, and approachability.

The Lawrence Microtomy Suite


To honour Andrew’s legacy, we have dedicated our expanding microtomy suite in his memory. This is a space where his passion for advancing science and technology will continue to inspire our team every day.

Help us raise funds for Pancreatic Cancer UK


Andrew’s family are helping to raise funds for Pancreatic Cancer UK, to support people with pancreatic cancer and fund vital research to transform the future for pancreatic cancer diagnosis and treatment.

Please help us support the fight against pancreatic cancer by clicking on the link below to donate what you can.


Find out more about our services

Stay up to date with HistologiX

Latest Insights & News